Generali Investments Management Co LLC Takes $64,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Generali Investments Management Co LLC purchased a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 7,022 shares of the health services provider’s stock, valued at approximately $64,000.

A number of other large investors also recently bought and sold shares of TDOC. Vinva Investment Management Ltd purchased a new stake in Teladoc Health in the 4th quarter valued at about $363,000. Xponance Inc. boosted its holdings in shares of Teladoc Health by 23.8% in the fourth quarter. Xponance Inc. now owns 13,861 shares of the health services provider’s stock valued at $126,000 after purchasing an additional 2,661 shares during the period. Cibc World Markets Corp bought a new position in Teladoc Health in the fourth quarter worth approximately $146,000. Commonwealth Equity Services LLC increased its holdings in Teladoc Health by 35.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 29,903 shares during the period. Finally, Swiss National Bank lifted its holdings in shares of Teladoc Health by 1.1% in the 4th quarter. Swiss National Bank now owns 336,702 shares of the health services provider’s stock worth $3,061,000 after buying an additional 3,600 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of Teladoc Health stock opened at $8.48 on Thursday. The company has a 50 day moving average price of $10.48 and a 200 day moving average price of $9.73. The firm has a market capitalization of $1.47 billion, a P/E ratio of -1.47 and a beta of 1.27. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $15.68.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Sell-side analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. The Goldman Sachs Group cut their target price on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Oppenheimer lowered their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Piper Sandler cut their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Finally, Bank of America boosted their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.